FDA Says Weight Loss Drug Lorcaserin May Increase Risk of Cancer

The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with …

Lilly Expands Affordability With Lower-Priced Versions of Popular Insulin

Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to …

Maker of Lantus Insulin Announces It Will Exit Diabetes Research

French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from …

Special Spotlight On Diabetes Prescription Drugs: Byetta (exenatide)

Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission …

Special Spotlight On Diabetes Prescription Drugs: Basaglar

Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD.  Republished with permission …

FDA Approves First Oral Formulation of Semaglutide For Adults with T2D

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2 …

Swiss Drugmaker Halts Distribution of Zantac Worldwide

Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global …

Health Insurer Introduces Insulin Cost Relief Program in North Dakota

A Minnesota based health insurer, Medica, announced today it will expand its cap on the maximum amount members in North Dakota will pay for their …

Glytec Develops New Solution for Selection and Dosing Diabetes Medications

Less than half of the estimated 22 million people prescribed one or more diabetes medications are maintaining blood sugar levels within the …

Special Spotlight On Diabetes Insulins: Invokana (canagliflozin)

Medically reviewed by Zara Risoldi Cochrane, PharmD, MS, FASCP on April 24, 2019 — Written by Victor Nguyen, PharmD, MS. Republished with …